Evaluating Walking Kinetic of Children Who Suffer Central Nervous System (CNS) Damage
This study is not yet open for participant recruitment.
Verified October 2011 by Sheba Medical Center
Sponsor:
Sheba Medical Center
Information provided by (Responsible Party):
Dr. Ofer Keren, Sheba Medical Center
ClinicalTrials.gov Identifier:
NCT01158027
First received: July 4, 2010
Last updated: October 17, 2011
Last verified: October 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The goal of the present study is to look at the effect of changing walking parameters on the dynamic walking characteristics among children post severe traumatic brain injury, and typically developed controls.
| Condition | Intervention |
|---|---|
|
Walking Performance |
Other: gait evaluation |
| Study Type: | Observational |
| Study Design: | Time Perspective: Cross-Sectional |
| Official Title: | Evaluating Walking Kinetic of Children Who Suffer Central Nervous System (CNS) |
Further study details as provided by Sheba Medical Center:
| Estimated Enrollment: | 30 |
| Study Start Date: | October 2011 |
| Groups/Cohorts | Assigned Interventions |
|---|---|
| children |
Other: gait evaluation
The children will asked to walk under different conditions: (1) walking at a self-selected speed faster and slower on the GAITRite® system and on a treadmill and while listening and to a metronomeQuoting.
|
Eligibility| Ages Eligible for Study: | 8 Years to 13 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Study Population
Fifteen children post-TBI and fifteen typically control.
Criteria
Inclusion Criteria:
- post-severe closed head injury (Glasgow Coma Scale [GCS] score at admission to emergency room of ≤8) [Kathryn 2008].
- at least one year post trauma.
- ages 7 to 13 years.
- independent ambulation (foot orthoses permitted).
Exclusion Criteria:
- had received botulinum toxin for spasticity management or had undergone orthopedic surgery in the past six months.
- unable to follow simple instructions.
Contacts and Locations
No Contacts or Locations Provided
More Information
No publications provided
| Responsible Party: | Dr. Ofer Keren, MD, Sheba Medical Center |
| ClinicalTrials.gov Identifier: | NCT01158027 History of Changes |
| Other Study ID Numbers: | SHEBA-10-7999-OK-CTIL |
| Study First Received: | July 4, 2010 |
| Last Updated: | October 17, 2011 |
| Health Authority: | Israel: Israeli Health Ministry Pharmaceutical Administration |
ClinicalTrials.gov processed this record on May 23, 2013